Joshua Fredell, PharmD

Vice President and Head of PBM & Specialty Product Innovation
Joshua Fredell, PharmD headshot

Joshua Fredell is Vice President and Head of PBM and Specialty Product Innovation at CVS Health. He oversees ideation, commercialization, and management of the company’s pharmacy benefit and specialty management products, including formulary design, network products and pricing approaches, specialty innovation, clinical solutions, and medical benefit management.

During his 19 years with the organization, Fredell has held leadership roles overseeing development of solutions and services that help make prescription medications more affordable and accessible, promote therapy adherence, prevent gaps in care, and manage spending. Most recently, he led formulary strategy to help prevent wasteful spend while ensuring plan members have access to clinically appropriate therapies.

Prior to CVS Health, Fredell was part of the pharmacy department of UPMC Health Plan and earned his PharmD from the University of Pittsburgh.

Specialty
Specialty Dermatologicals Continue to Be High Cost Drivers More
Briefing
Drug Pipeline
New Treatments for Alopecia Areata on the Horizon More
Briefing
Specialty
The First Biosimilar to Humira Is Here More
Briefing
Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Cost Management
CVS Caremark Announces Formulary Changes for 2023 More
Briefing
Specialty
Multiple Specialty Vendors Mean More Headaches More
Commentary
Drug Pipeline
Teplizumab: Potential Breakthrough Therapy for Type 1 Diabetes More
Briefing
Cost Management
CVS Health’s Hyperinflation Strategy Helps Clients Reduce Unnecessary Drug Spend More
Briefing